23/07/2026
Cancer Research Malaysia is proud of our Board of Trustees member, Dr Voon Pei Jye, Head and Consultant Medical Oncologist, Department of Radiotherapy and Oncology, Sarawak General Hospital, on his presentation at the American Association for Cancer Research (AACR) Drug Discovery and Development (AACR D3) meeting in Boston, Massachusetts.
Speaking in the session “Global Drug Discovery and Development: Progress, Challenges, and the Path Forward”, Dr Voon shared Malaysia’s experience in developing oncology clinical trials and the growth of clinical research in Sarawak.
It was a particularly proud moment to see Malaysian expertise represented at the AACR D3 global conference, reflecting our country’s growing contribution to international oncology research and drug development.
Malaysia’s expanding clinical trial landscape is essential to strengthening our capacity to develop and evaluate new cancer treatments, and to ensuring that Asian patients are represented in the research shaping the future of cancer care.
At Cancer Research Malaysia, we are excited by this momentum. Our work spans the translational pathway, from discovering new therapeutic targets and developing cancer vaccines to conducting clinical trials. Strong partnerships among scientists, clinicians, hospitals, industry and patients are essential to move promising discoveries from the laboratory into treatments that benefit patients.
More about AACR D3: https://www.aacr.org/meeting/aacr-d3-2026/
FB Rasmi Hospital Umum Sarawak